ClinicalTrials.gg
Drug

Nusinersen clinical trials

Also written BIIB058, Spinraza and ISIS 396443.

studies test it
19
open now
3
in phase 3
7
first study started
2011

How each study uses nusinersen is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the nusinersen studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
23 Dec 2016 · SPINRAZA · NDA 209531 (FDA, Drugs@FDA)
European Union
30 May 2017 · Spinraza · EMEA/H/C/004312 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Nusinersen
16
ISIS SMNRx
7
IONIS-SMN Rx
4
IONIS SMN Rx
3
Sprinraza
2

Brand

Spinraza
12

Development codes

BIIB058
15
ISIS 396443
11

Studies by the year they started

19 studies that test it; most in 2014 (3)

Studies that test nusinersen, by start year
YearStudies
20111
20121
20132
20143
20153
20191
20201
20212
20222
20251
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
5
Phase 2
4
Phase 3
7
Phase 4
1
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 15 · Other 4

Biogen (15) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (2) · CHU de Reims (1) · NYU Langone Health (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test nusinersen, phase 3 first.

Studies

Open first, then newest update. How each study uses nusinersen is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 19

Given beside what is tested · 1 — nusinersen is usual care or a partner of the new treatment

Codes

What other systems call nusinersen · ClinicalTrials.gg INT000051

  • MeSH (NLM) C000590926nusinersenConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 5Z9SP3X666NUSINERSENConfirmed FDA, NLM
  • RxNorm 1863556One source FDA
  • NCI Thesaurus C166875NusinersenOne source FDA

Also registered as nusinersen sodium (UNII 4CHB7QQU1Q).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.